HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®

·17 Aug
Share:PostShare

— First global Phase III trial to show significant progression-free and overall survival benefits in this setting

G

Globe Newswire

Original source

Read full story

plus

Check live status on DownRightNow

Check status →

Related Stories

Health11h ago

NSW's historic MND data drive - Shepparton News

NSW's historic MND data drive Shepparton News New hope in quest to solve mystery of MND hotspots ABC News & Headlines – Australian Broadcasting Corporation Major MND move must go nationwide for research boost The Canberra Times Your risk of Motor Neurone Disease where you live: "Australians would be shocked". SBS Incurable disease spreads, cause unknown News.com.au

GGoogle News

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer